115 related articles for article (PubMed ID: 7923778)
1. Chemistry of the fructosamine assay: D-glucosone is the product of oxidation of Amadori compounds.
Baker JR; Zyzak DV; Thorpe SR; Baynes JW
Clin Chem; 1994 Oct; 40(10):1950-5. PubMed ID: 7923778
[TBL] [Abstract][Full Text] [Related]
2. Mechanism of fructosamine assay: evidence against role of superoxide as intermediate in nitroblue tetrazolium reduction.
Baker JR; Zyzak DV; Thorpe SR; Baynes JW
Clin Chem; 1993 Dec; 39(12):2460-5. PubMed ID: 8252716
[TBL] [Abstract][Full Text] [Related]
3. Mechanism of the degradation of non-enzymatically glycated proteins under physiological conditions. Studies with the model fructosamine, N epsilon-(1-deoxy-D-fructos-1-yl)hippuryl-lysine.
Smith PR; Thornalley PJ
Eur J Biochem; 1992 Dec; 210(3):729-39. PubMed ID: 1483456
[TBL] [Abstract][Full Text] [Related]
4. Identification of N epsilon-carboxymethyllysine as a degradation product of fructoselysine in glycated protein.
Ahmed MU; Thorpe SR; Baynes JW
J Biol Chem; 1986 Apr; 261(11):4889-94. PubMed ID: 3082871
[TBL] [Abstract][Full Text] [Related]
5. Effect of nitroblue tetrazolium concentration on the fructosamine assay for quantifying glycated protein.
Chung HF; Lees H; Gutman SI
Clin Chem; 1988 Oct; 34(10):2106-11. PubMed ID: 3168224
[TBL] [Abstract][Full Text] [Related]
6. Is serum fructosamine assay specific for determination of glycated serum protein?
Schleicher ED; Mayer R; Wagner EM; Gerbitz KD
Clin Chem; 1988 Feb; 34(2):320-3. PubMed ID: 3124979
[TBL] [Abstract][Full Text] [Related]
7. Fructosamine Test-Plus, a modified fructosamine assay evaluated.
Baker J; Metcalf P; Scragg R; Johnson R
Clin Chem; 1991 Apr; 37(4):552-6. PubMed ID: 2015670
[TBL] [Abstract][Full Text] [Related]
8. Mechanism of autoxidative glycosylation: identification of glyoxal and arabinose as intermediates in the autoxidative modification of proteins by glucose.
Wells-Knecht KJ; Zyzak DV; Litchfield JE; Thorpe SR; Baynes JW
Biochemistry; 1995 Mar; 34(11):3702-9. PubMed ID: 7893666
[TBL] [Abstract][Full Text] [Related]
9. Formation of reactive intermediates from Amadori compounds under physiological conditions.
Zyzak DV; Richardson JM; Thorpe SR; Baynes JW
Arch Biochem Biophys; 1995 Jan; 316(1):547-54. PubMed ID: 7840665
[TBL] [Abstract][Full Text] [Related]
10. Oxidative degradation of glucose adducts to protein. Formation of 3-(N epsilon-lysino)-lactic acid from model compounds and glycated proteins.
Ahmed MU; Dunn JA; Walla MD; Thorpe SR; Baynes JW
J Biol Chem; 1988 Jun; 263(18):8816-21. PubMed ID: 3132453
[TBL] [Abstract][Full Text] [Related]
11. Aminoguanidine inhibits protein browning without extensive Amadori carbonyl blocking.
Requena JR; Vidal P; Cabezas-Cerrato J
Diabetes Res Clin Pract; 1993 Jan; 19(1):23-30. PubMed ID: 8472617
[TBL] [Abstract][Full Text] [Related]
12. Peroxynitrite induces formation of N( epsilon )-(carboxymethyl) lysine by the cleavage of Amadori product and generation of glucosone and glyoxal from glucose: novel pathways for protein modification by peroxynitrite.
Nagai R; Unno Y; Hayashi MC; Masuda S; Hayase F; Kinae N; Horiuchi S
Diabetes; 2002 Sep; 51(9):2833-9. PubMed ID: 12196478
[TBL] [Abstract][Full Text] [Related]
13. Correlation between glycated lipoproteins and fructosamine level in serum.
Kobayashi K; Ogasahara N; Sakoguchi T; Taishi K; Makimura H; Matsuoka A
Chem Pharm Bull (Tokyo); 1991 Aug; 39(8):2149-51. PubMed ID: 1797439
[TBL] [Abstract][Full Text] [Related]
14. Colorimetric determination of fructosamine in hemolytic samples for the postmortem diagnosis of diabetes mellitus.
Akane A; Shiono H; Matsubara K; Tanabe K; Fukushima S; Takahashi S; Nakamura H; Hasegawa M; Kagawa M
Nihon Hoigaku Zasshi; 1991 Dec; 45(5-6):367-74. PubMed ID: 1811101
[TBL] [Abstract][Full Text] [Related]
15. Immunoglobulin-G Glycation by Fructose Leads to Structural Perturbations and Drop Off in Free Lysine and Arginine Residues.
Faisal M; Alatar AA; Ahmad S
Protein Pept Lett; 2017; 24(3):241-244. PubMed ID: 28124608
[TBL] [Abstract][Full Text] [Related]
16. Measurement of glycated albumin by the nitroblue tetrazolium colorimetric method.
Mashiba S; Uchida K; Okuda S; Tomita S
Clin Chim Acta; 1992 Nov; 212(1-2):3-15. PubMed ID: 1486680
[TBL] [Abstract][Full Text] [Related]
17. [Assay of fructosamine. Value and limits in diabetology].
Leutenegger M; Gillery P; Gross A; Pasqual C; Ostermann G; Durlach V
Ann Biol Clin (Paris); 1989; 47(3):121-5. PubMed ID: 2712398
[TBL] [Abstract][Full Text] [Related]
18. Fructosamine assay modified for the estimation of glycated hemoglobin.
Somani BL; Sinha R; Gupta MM
Clin Chem; 1989 Mar; 35(3):497. PubMed ID: 2920425
[No Abstract] [Full Text] [Related]
19. Influence of pH and phosphate ions on the kinetics of enolisation and degradation of fructosamines. Studies with the model fructosamine, N epsilon-1-deoxy-D-fructos-1-yl-hippuryl-lysine.
Smith PR; Thornalley PJ
Biochem Int; 1992 Nov; 28(3):429-39. PubMed ID: 1482387
[TBL] [Abstract][Full Text] [Related]
20. Evidence against the formation of 2-amino-6-(2-formyl-5-hydroxymethyl-pyrrol-1-yl)-hexanoic acid ('pyrraline') as an early-stage product or advanced glycation end product in non-enzymic protein glycation.
Smith PR; Somani HH; Thornalley PJ; Benn J; Sonksen PH
Clin Sci (Lond); 1993 Jan; 84(1):87-93. PubMed ID: 8382140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
